Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1861-1870 of 2869 for cancer

Edit search filters
  1. A Randomized Study Of Olaparib Or Placebo In Patients With Surgically Removed Pancreatic Cancer Who Have A BRCA1, BRCA2 Or PALB2 Mutation, The APOLLO Trial

    Rochester, MN

  2. Durvalumab And Tremelimumab With Or Without High Or Low-Dose Radiation Therapy In Treating Patients With Metastatic Colorectal Or Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study To Learn About The Medicine Ponsegromab In Adults With Cancer Of The Pancreas Which Has Spread And Caused Significant Body Weight Loss And Fatigue

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. A Study Of Raludotatug Deruxtecan (R-DXd) In Subjects With Platinum-resistant, High Grade Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Jacksonville, FL

  5. A Study To Evaluate Biomarker/ALK Inhibitor Combinations In Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol)

    Rochester, MN

  6. A Study To Evaluate Gemcitabine, Cisplatin, And Nab-Paclitaxel To Treat Patients With High-Risk Liver Bile Duct Cancer Before Surgery

    Rochester, MN

  7. Brightline-4: A Study To Test How Well Brigimadlin Is Tolerated By People With A Type Of Cancer Called Dedifferentiated Liposarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Antiandrogen Therapy And Radiation Therapy With Or Without Docetaxel In Treating Patients With Prostate Cancer That Has Been Removed By Surgery

    Albert Lea, MN, Mankato, MN, Rochester, MN

  9. A Study to Determine if the Drug Gemfibrozil Changes How Oxygen is Transported in Blood

    Rochester, MN

  10. Allogeneic Stem Cell Transplantation for Patients with Severe Aplastic Anemia

    Rochester, MN

.

Mayo Clinic Footer